文献速递糖尿病肥胖与代谢综合征

内脏脂肪面积与糖尿病肾病风险:性别与BMI特异性关联的大型前瞻性队列研究

Sex-specific and BMI-specific associations between visceral fat and diabetic kidney disease in patients with diabetes: a large-scale multicentre prospective cohort study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2026-01-01

男性呈U型关系,低VFA(≤50 cm2)和高VFA(>100 cm2)均增加风险;女性仅在VFA>75 cm2后风险升高。该关联在不同BMI分层中持续存在,低VFA男性为既往被忽视的高危人群。

要点

  • 男性VFA与糖尿病肾病呈U型关系,低VFA(≤50 cm2)和高VFA均增加风险。
  • 女性VFA>75 cm2后糖尿病肾病风险显著升高,肥胖女性风险起点更低。

核心结论

  • VFA是糖尿病肾病的显著危险因素,且存在性别特异性模式,该模式在不同BMI分层中持续存在。
  • 低VFA男性是既往被忽视的高危人群,支持精准临床风险分层。

研究设计与样本

  • 前瞻性队列研究,纳入中国代谢管理中心项目640家中心的成人糖尿病患者。
  • 采用Cox回归分析VFA与糖尿病肾病的关联,按性别和BMI分层。

关键数值与推荐

  • VFA分组阈值:≤50 cm2、50–75 cm2、75–100 cm2、100–125 cm2、>125 cm2。
  • BMI分层:非超重<24 kg/m2,超重24–28 kg/m2,肥胖≥28 kg/m2。

临床怎么用

  • 临床应关注糖尿病患者VFA水平,尤其男性低VFA(≤50 cm2)者,不应仅因BMI正常而忽视其糖尿病肾病风险。
  • 女性VFA>75 cm2时风险升高,肥胖女性VFA在50–75 cm2即需警惕。
  • VFA测量(生物电阻抗分析)可用于糖尿病肾病风险分层,结合性别和BMI进行精准评估。

局限性

  • VFA通过生物电阻抗分析测量,非影像学金标准。
  • 研究人群为中国糖尿病患者,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are few large-scale prospective studies on directly measured visceral fat area (VFA) and diabetic kidney disease, with inconsistent findings across sex and BMI. We aimed to investigate the association between VFA and incident diabetic kidney disease risk and to examine how this association differs by sex and BMI. METHODS: This prospective cohort study included adults with diabetes from 640 centres in the China Metabolic Management Center (MMC) project. We included adult participants with diabetes who had baseline and follow-up diabetic kidney disease data, excluding those with prevalent diabetic kidney disease at baseline or missing baseline VFA data. Diabetes diagnosis was confirmed by an on-site physician at enrollment. Diabetic kidney disease was defined as albuminuria (urinary albumin-to-creatinine ratio ≥3·39 mg/mmol) or estimated glomerular filtration rate less than 60 mL/min per 1·73m2. VFA was measured by bioelectrical impedance analysis. Cox regression analysis was used to evaluate the association between VFA and diabetic kidney disease, with stratification by sex and BMI categories. The MMC project is registered at ClinicalTrials.gov, NCT03811470. FINDINGS: Between June 1, 2017, and June 26, 2024, we recruited 308 512 participants aged 18 years or older with a diagnosis of diabetes who had undergone baseline diabetic kidney disease assessment and had accessible follow-up records up to June 21, 2025. After excluding participants with baseline diabetic kidney disease (n=113 383), incomplete VFA measurements (n=41 979), or missing diabetic kidney disease assessment during follow-up (n=59 618), the final analytical cohort consisted of 93 532 participants. Participants had a median follow-up of 18·4 months (IQR 9·4-32·3) and a median age of 55·0 years (IQR 46·0-62·0). 57 865 [61·9%] of 93 532 participants were male and 35 667 (38·1%) were female. 27 486 (29·4%) of 93 532 participants developed diabetic kidney disease. VFA was significantly associated with increased diabetic kidney disease risk (per IQR [52 cm2] adjusted hazard ratio [aHR] 1·08, 95% CI 1·05-1·10; p<0·0001). Sex-stratified categorical analyses showed increased diabetic kidney disease risk in men at both low VFA (≤50 cm2; aHR 1·12, 1·06-1·19; p=0·0002) and high VFA greater than 100 cm2 (100-125 cm2; 1·06, 1·01-1·11; p=0·013), while women showed significantly increased risk only at VFA greater than 75 cm2 (75-100 cm2; 1·09, 1·03-1·14; p=0·0014). In male participants, a U-shaped relationship was consistently observed. Male participants without overweight (BMI <24 kg/m2) had elevated risks at VFA extremes (≤50 cm2 aHR 1·12, 95% CI 1·04-1·21; p=0·0045 and >125 cm2 aHR 1·25, 1·09-1·44; p=0·0019). This U-shape persisted in male participants with overweight (BMI 24-28 kg/m2), with significant risks at VFA 50 cm2 or less (aHR 1·15, 95% CI 1·01-1·31; p=0·039), 100-125 cm2 (1·10, 1·02-1·18; p=0·010), and greater than 125 cm2 (1·15, 1·06-1·24; p=0·0005). In male participants with obesity (BMI ≥28 kg/m2), risk was significantly elevated across all VFA categories, highest at both extremes (≤50 cm2 aHR 2·15, 95% CI 1·44-3·23; p=0·0002 and >125 cm2 aHR 1·31, 1·20-1·42; p<0·0001). In female participants, disease risk was elevated from VFA greater than 75 cm2 in both participants without overweight (75-100 cm2 aHR 1·10, 95% CI 1·02-1·19; p=0·011) and participants with overweight (75-100 cm2 1·10, 1·02-1·17; p=0·011), while obesity extended significant risk to lower VFA levels (50-75 cm2 aHR 1·22, 95% CI 1·02-1·46; p=0·033). INTERPRETATION: VFA is a significant risk factor for diabetic kidney disease, exhibiting distinct sex-specific patterns that persist across BMI strata. These findings support precise clinical risk stratification and identify low-VFA men as a previously overlooked high-risk population. FUNDING: Noncommunicable Chronic Diseases-National Science and Technology Major Project.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Shi J, Zhao D, Wang J, et al. Sex-specific and BMI-specific associations between visceral fat and diabetic kidney disease in patients with diabetes: a large-scale multicentre prospective cohort study. Lancet Diabetes Endocrinol. 2026. PMID: 41991218. doi:10.1016/S2213-8587(26)00001-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。